NM_182961.4(SYNE1):c.26279G>A (p.Gly8760Glu) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Oct 4, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001236099.16

Allele description [Variation Report for NM_182961.4(SYNE1):c.26279G>A (p.Gly8760Glu)]

NM_182961.4(SYNE1):c.26279G>A (p.Gly8760Glu)

Genes:

ESR1:estrogen receptor 1 [Gene - OMIM - HGNC]
SYNE1:spectrin repeat containing nuclear envelope protein 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

6q25.2

Genomic location:

Preferred name:

NM_182961.4(SYNE1):c.26279G>A (p.Gly8760Glu)

HGVS:

NC_000006.12:g.152122551C>T
NG_008493.2:g.470861C>T
NG_012855.2:g.519849G>A
NM_001328100.2:c.851-2715C>T
NM_001347701.2:c.*90G>A
NM_001347702.2:c.2813G>A
NM_033071.5:c.26135G>A
NM_182961.4:c.26279G>AMANE SELECT
NP_001334631.1:p.Gly938Glu
NP_149062.1:p.Gly8712Glu
NP_149062.2:p.Gly8712Glu
NP_892006.3:p.Gly8760Glu
LRG_427t1:c.26279G>A
LRG_427t2:c.26135G>A
LRG_427:g.519849G>A
LRG_427p1:p.Gly8760Glu
LRG_427p2:p.Gly8712Glu
LRG_992:g.470861C>T
NC_000006.11:g.152443686C>T
NM_033071.3:c.26135G>A
NM_182961.2:c.26279G>A

Protein change:

G8712E

Links:

dbSNP: rs747635401

NCBI 1000 Genomes Browser:

rs747635401

Molecular consequence:

NM_001347701.2:c.*90G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
NM_001328100.2:c.851-2715C>T - intron variant - [Sequence Ontology: SO:0001627]
NM_001347702.2:c.2813G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_033071.5:c.26135G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_182961.4:c.26279G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Autosomal recessive ataxia, Beauce type
Synonyms:: ATAXIA, RECESSIVE, OF BEAUCE; Spinocerebellar ataxia, autosomal recessive 8; SYNE1-Related Autosomal Recessive Cerebellar Ataxia
Identifiers:: MONDO: MONDO:0012549; MedGen: C1853116; Orphanet: 88644; OMIM: 610743

Name:: Emery-Dreifuss muscular dystrophy 4, autosomal dominant (EDMD4)
Synonyms:: EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES
Identifiers:: MONDO: MONDO:0013071; MedGen: C2751807; Orphanet: 261; OMIM: 612998

Recent activity

Clear Turn Off Turn On

Mus musculus androgen binding protein gamma, mRNA (cDNA clone MGC:161784 IMAGE:4...
Mus musculus androgen binding protein gamma, mRNA (cDNA clone MGC:161784 IMAGE:40134662), complete cds
gi|170016227|gb|BC148302.2|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001408811	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Oct 4, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001408811

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Oct 4, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001408811.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

ClinVar contains an entry for this variant (Variation ID: 962272). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. This variant is present in population databases (rs747635401, gnomAD 0.005%). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 8712 of the SYNE1 protein (p.Gly8712Glu).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine